glp 1/gip agonist Main physiological actions of the dual GIP and GLP-1 GLP-1 Receptor Agonists Explained for

10.1038/nature21029 43 LimJ

Specific warnings include the risk of aspiration for patients, the need for patients to inform their anaesthetist they are taking these medications, and for anaesthetists to consider the heightened risk of aspiration and to manage such patients accordingly

Taking GLP-1s was particularly associated with a reduced risk of endometrial, ovarian and meningioma cancers

52,53 The improvement of antioxidant stress through GLP-1 signaling seems to be related to the activation of the GLP-1 R/cAMP/PKA signaling pathway and nuclear factor erythroid 2-related factor 2/heme oxygenase 1 signaling pathway